By Liebe Griebenauw and Peter McCusker FOUR firms have been sanctioned in the latest crackdown by the United States Food and Drug Administration on businesses making medical claims for their CBD products. One of these, Cannafyl of Arizona, was advertising their products as being ‘intended to mitigate, prevent, treat, diagnose, or cure COVID-19’. This is not…
Source link